IQAI

Iq-ai (IQAI)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:IQAI
DataOraFonteTitoloSimboloCompagnia
02/05/202416:45Alliance NewsAlliance NewsEARNINGS AND TRADING: Trident Royalties swings to profitLSE:IQAIIq-ai Limited
02/05/202413:47RNS Regulatory NewsIQ-AI Limited IB Announces Expanded Access Program for GaMLSE:IQAIIq-ai Limited
29/04/202416:26RNS Regulatory NewsIQ-AI Limited Publication of Annual ReportLSE:IQAIIq-ai Limited
05/03/202408:00RNS Regulatory NewsIQ-AI Limited Grant of OptionsLSE:IQAIIq-ai Limited
01/03/202409:22RNS Regulatory NewsIQ-AI Limited Holding(s) in CompanyLSE:IQAIIq-ai Limited
26/02/202408:00RNS Regulatory NewsIQ-AI Limited Result of Broker Option and Total Voting RightsLSE:IQAIIq-ai Limited
22/02/202415:02Alliance NewsAlliance NewsIN BRIEF: IQ-AI shares sink on discounted placing fundraiseLSE:IQAIIq-ai Limited
22/02/202408:00RNS Regulatory NewsIQ-AI Limited Placing and Broker OptionLSE:IQAIIq-ai Limited
09/02/202414:38Alliance NewsAlliance NewsIQ-AI subsidiary asked by FDA to resubmit and modify applicationLSE:IQAIIq-ai Limited
09/02/202413:49RNS Regulatory NewsIQ-AI Limited FDA Application UpdateLSE:IQAIIq-ai Limited
02/02/202409:56Alliance NewsAlliance NewsIN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiaryLSE:IQAIIq-ai Limited
02/02/202409:39RNS Regulatory NewsIQ-AI Limited IB awarded a $100,000 grantLSE:IQAIIq-ai Limited
15/01/202408:01UK RegulatoryIQ-AI Limited Director Dealings and Conversion of CLNsLSE:IQAIIq-ai Limited
10/01/202412:48Alliance NewsAlliance NewsIQ-AI falls after subsidiary notes launch of treatment access schemeLSE:IQAIIq-ai Limited
10/01/202408:00UK RegulatoryIQ-AI Limited IB Launching an Expanded Access Program for GaMLSE:IQAIIq-ai Limited
19/12/202318:00Alliance NewsAlliance NewsIQ-AI firm gets US FDA fast-track status for oral gallium maltolateLSE:IQAIIq-ai Limited
19/12/202315:29UK RegulatoryIQ-AI Limited Imaging Biometrics granted FDA "Fast-Track"LSE:IQAIIq-ai Limited
05/12/202312:49Alliance NewsAlliance NewsIQ-AI stock rises on positive interim results from glioblastoma trialLSE:IQAIIq-ai Limited
05/12/202311:58UK RegulatoryIQ-AI Limited IQ-AI Announces Positive Interim Phase 1 ResultsLSE:IQAIIq-ai Limited
09/11/202312:38UK RegulatoryIQ-AI Limited Director Dealing and Conversion of CLNsLSE:IQAIIq-ai Limited
08/11/202313:04Alliance NewsAlliance NewsIQ-AI says Imaging Biometrics submits paediatric rare disease requestLSE:IQAIIq-ai Limited
08/11/202311:59UK RegulatoryIQ-AI Limited Application for Pediatric Rare Disease DesignationLSE:IQAIIq-ai Limited
18/10/202318:11Alliance NewsAlliance NewsIN BRIEF: IQ-AI subsidiary "central" to "landmark" brain cancer studyLSE:IQAIIq-ai Limited
18/10/202315:29UK RegulatoryIQ-AI Limited Update Regarding Imaging Biometrics LLCLSE:IQAIIq-ai Limited
13/10/202309:55UK RegulatoryIQ-AI Limited IB Letter to ShareholdersLSE:IQAIIq-ai Limited
09/10/202313:09Alliance NewsAlliance NewsIN BRIEF: IQ-AI subsidiary wins orphan drug designation from US FDALSE:IQAIIq-ai Limited
09/10/202308:00UK RegulatoryIQ-AI Limited Orphan Drug Status to GaM and Total Voting RightsLSE:IQAIIq-ai Limited
19/09/202315:34Alliance NewsAlliance News*IQ-AI says decides to stop trading on OTCQB Venture Market in US as no trading since NovLSE:IQAIIq-ai Limited
19/09/202315:32UK RegulatoryIQ-AI Limited IQ-AI shares cease trading on the OTCQBLSE:IQAIIq-ai Limited
08/09/202311:25Alliance NewsAlliance NewsIQ-AI notes vindication of subsidiary's reduced gadolinium approachLSE:IQAIIq-ai Limited
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:IQAI
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network